5 Biotech Stocks to Buy for a Q4 Rally

Biotech stocks have been a consistent area of weakness, but things are turning around for the battered sector. More 

7 Corporate Tax Dodgers Paying Less Than 15% Rates

Whatever you think about government spending, the cash has to come from somewhere -- and these corporate tax dodgers aren't paying their share. More 

GILD Stock: What Investors Really Want to See From Q3

Gilead Science's Q3 numbers aren't as important to GILD stock compared to what it does to solidify the future. More 

3 Undervalued Biotech Stocks To Buy

Despite the sharp correction in the heath care sector, these three biotech stocks should recover off of their strong fundamentals. More 

6 Stocks to Buy for the Next Decade

These six stocks to buy for the long-term have made the moves necessary to ensure resiliency (and even growth) in the decade ahead. More 

4 Biotech Stocks Now at Bargain Prices

Biotech stocks have been battered of late, but not all these biotechnology names deserved their drubbing. Here are four to pick up while the dust is still settling. More 

Biggest Movers in Healthcare Stocks Now – EXAS REGN AMGN CELG

Healthcare stocks rose broadly on Wall Street on Wednesday morning, with the sector seeing an overall increase of 0.7%. More